Global Nifedipine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Market Overview
The global Nifedipine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nifedipine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nifedipine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nifedipine market has been segmented into
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
By Application, Nifedipine has been segmented into:
Primary Pulmonary Hypertension
Heart Failure
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nifedipine market presented in the report. This section sheds light on the sales growth of different regional and country-level Nifedipine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nifedipine market.
The report offers in-depth assessment of the growth and other aspects of the Nifedipine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nifedipine Market Share Analysis
Nifedipine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nifedipine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nifedipine sales, revenue and market share for each player covered in this report.
The major players covered in Nifedipine are:
Bayer (Germany)
Yabao (China)
Pfizer (USA)
Actavis (USA)
Huanghai (China)
Teva (Israel)
Honglin (China)
Shyndec (China)
Among other players domestic and global, Nifedipine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nifedipine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nifedipine, with price, sales, revenue and global market share of Nifedipine in 2018 and 2019.
Chapter 3, the Nifedipine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nifedipine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nifedipine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nifedipine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nifedipine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nifedipine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Nifedipine Controlled Release Tablets
1.2.3 Nifedipine Extended Action Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Nifedipine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Primary Pulmonary Hypertension
1.3.3 Heart Failure
1.3.4 Others
1.4 Overview of Global Nifedipine Market
1.4.1 Global Nifedipine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer (Germany)
2.1.1 Bayer (Germany) Details
2.1.2 Bayer (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer (Germany) SWOT Analysis
2.1.4 Bayer (Germany) Product and Services
2.1.5 Bayer (Germany) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Yabao (China)
2.2.1 Yabao (China) Details
2.2.2 Yabao (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Yabao (China) SWOT Analysis
2.2.4 Yabao (China) Product and Services
2.2.5 Yabao (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer (USA)
2.3.1 Pfizer (USA) Details
2.3.2 Pfizer (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer (USA) SWOT Analysis
2.3.4 Pfizer (USA) Product and Services
2.3.5 Pfizer (USA) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Actavis (USA)
2.4.1 Actavis (USA) Details
2.4.2 Actavis (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Actavis (USA) SWOT Analysis
2.4.4 Actavis (USA) Product and Services
2.4.5 Actavis (USA) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Huanghai (China)
2.5.1 Huanghai (China) Details
2.5.2 Huanghai (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Huanghai (China) SWOT Analysis
2.5.4 Huanghai (China) Product and Services
2.5.5 Huanghai (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva (Israel)
2.6.1 Teva (Israel) Details
2.6.2 Teva (Israel) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva (Israel) SWOT Analysis
2.6.4 Teva (Israel) Product and Services
2.6.5 Teva (Israel) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Honglin (China)
2.7.1 Honglin (China) Details
2.7.2 Honglin (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Honglin (China) SWOT Analysis
2.7.4 Honglin (China) Product and Services
2.7.5 Honglin (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Shyndec (China)
2.8.1 Shyndec (China) Details
2.8.2 Shyndec (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Shyndec (China) SWOT Analysis
2.8.4 Shyndec (China) Product and Services
2.8.5 Shyndec (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nifedipine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nifedipine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nifedipine Manufacturer Market Share in 2019
3.3.2 Top 6 Nifedipine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nifedipine Sales, Revenue and Market Share by Regions
4.1.1 Global Nifedipine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nifedipine Revenue and Market Share by Regions (2015-2020)
4.2 North America Nifedipine Sales and Growth Rate (2015-2020)
4.3 Europe Nifedipine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nifedipine Sales and Growth Rate (2015-2020)
4.5 South America Nifedipine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nifedipine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nifedipine Sales, Revenue and Market Share by Country
5.1.1 North America Nifedipine Sales and Market Share by Country (2015-2020)
5.1.2 North America Nifedipine Revenue and Market Share by Country (2015-2020)
5.2 United States Nifedipine Sales and Growth Rate (2015-2020)
5.3 Canada Nifedipine Sales and Growth Rate (2015-2020)
5.4 Mexico Nifedipine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nifedipine Sales, Revenue and Market Share by Country
6.1.1 Europe Nifedipine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nifedipine Revenue and Market Share by Country (2015-2020)
6.2 Germany Nifedipine Sales and Growth Rate (2015-2020)
6.3 UK Nifedipine Sales and Growth Rate (2015-2020)
6.4 France Nifedipine Sales and Growth Rate (2015-2020)
6.5 Russia Nifedipine Sales and Growth Rate (2015-2020)
6.6 Italy Nifedipine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nifedipine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nifedipine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nifedipine Revenue and Market Share by Regions (2015-2020)
7.2 China Nifedipine Sales and Growth Rate (2015-2020)
7.3 Japan Nifedipine Sales and Growth Rate (2015-2020)
7.4 Korea Nifedipine Sales and Growth Rate (2015-2020)
7.5 India Nifedipine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nifedipine Sales and Growth Rate (2015-2020)
7.7 Australia Nifedipine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nifedipine Sales, Revenue and Market Share by Country
8.1.1 South America Nifedipine Sales and Market Share by Country (2015-2020)
8.1.2 South America Nifedipine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nifedipine Sales and Growth Rate (2015-2020)
8.3 Argentina Nifedipine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nifedipine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nifedipine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nifedipine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nifedipine Sales and Growth Rate (2015-2020)
9.3 Turkey Nifedipine Sales and Growth Rate (2015-2020)
9.4 Egypt Nifedipine Sales and Growth Rate (2015-2020)
9.5 South Africa Nifedipine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nifedipine Sales and Market Share by Type (2015-2020)
10.2 Global Nifedipine Revenue and Market Share by Type (2015-2020)
10.3 Global Nifedipine Price by Type (2015-2020)
11 Global Nifedipine Market Segment by Application
11.1 Global Nifedipine Sales Market Share by Application (2015-2020)
11.2 Global Nifedipine Revenue Market Share by Application (2015-2020)
11.3 Global Nifedipine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nifedipine Sales, Revenue and Growth Rate (2021-2025)
12.2 Nifedipine Market Forecast by Regions (2021-2025)
12.2.1 North America Nifedipine Market Forecast (2021-2025)
12.2.2 Europe Nifedipine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nifedipine Market Forecast (2021-2025)
12.2.4 South America Nifedipine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nifedipine Market Forecast (2021-2025)
12.3 Nifedipine Market Forecast by Type (2021-2025)
12.3.1 Global Nifedipine Sales Forecast by Type (2021-2025)
12.3.2 Global Nifedipine Market Share Forecast by Type (2021-2025)
12.4 Nifedipine Market Forecast by Application (2021-2025)
12.4.1 Global Nifedipine Sales Forecast by Application (2021-2025)
12.4.2 Global Nifedipine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global Nifedipine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nifedipine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nifedipine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer (Germany) Basic Information, Manufacturing Base and Competitors
Table 8. Bayer (Germany) Nifedipine Major Business
Table 9. Bayer (Germany) Nifedipine Total Revenue (USD Million) (2017-2018)
Table 10. Bayer (Germany) SWOT Analysis
Table 11. Bayer (Germany) Nifedipine Product and Services
Table 12. Bayer (Germany) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Yabao (China) Basic Information, Manufacturing Base and Competitors
Table 14. Yabao (China) Nifedipine Major Business
Table 15. Yabao (China) Nifedipine Total Revenue (USD Million) (2017-2018)
Table 16. Yabao (China) SWOT Analysis
Table 17. Yabao (China) Nifedipine Product and Services
Table 18. Yabao (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer (USA) Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer (USA) Nifedipine Major Business
Table 21. Pfizer (USA) Nifedipine Total Revenue (USD Million) (2017-2018)
Table 22. Pfizer (USA) SWOT Analysis
Table 23. Pfizer (USA) Nifedipine Product and Services
Table 24. Pfizer (USA) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Actavis (USA) Basic Information, Manufacturing Base and Competitors
Table 26. Actavis (USA) Nifedipine Major Business
Table 27. Actavis (USA) Nifedipine Total Revenue (USD Million) (2017-2018)
Table 28. Actavis (USA) SWOT Analysis
Table 29. Actavis (USA) Nifedipine Product and Services
Table 30. Actavis (USA) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Huanghai (China) Basic Information, Manufacturing Base and Competitors
Table 32. Huanghai (China) Nifedipine Major Business
Table 33. Huanghai (China) Nifedipine Total Revenue (USD Million) (2017-2018)
Table 34. Huanghai (China) SWOT Analysis
Table 35. Huanghai (China) Nifedipine Product and Services
Table 36. Huanghai (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva (Israel) Basic Information, Manufacturing Base and Competitors
Table 38. Teva (Israel) Nifedipine Major Business
Table 39. Teva (Israel) Nifedipine Total Revenue (USD Million) (2017-2018)
Table 40. Teva (Israel) SWOT Analysis
Table 41. Teva (Israel) Nifedipine Product and Services
Table 42. Teva (Israel) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Honglin (China) Basic Information, Manufacturing Base and Competitors
Table 44. Honglin (China) Nifedipine Major Business
Table 45. Honglin (China) Nifedipine Total Revenue (USD Million) (2017-2018)
Table 46. Honglin (China) SWOT Analysis
Table 47. Honglin (China) Nifedipine Product and Services
Table 48. Honglin (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Shyndec (China) Basic Information, Manufacturing Base and Competitors
Table 50. Shyndec (China) Nifedipine Major Business
Table 51. Shyndec (China) Nifedipine Total Revenue (USD Million) (2017-2018)
Table 52. Shyndec (China) SWOT Analysis
Table 53. Shyndec (China) Nifedipine Product and Services
Table 54. Shyndec (China) Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Nifedipine Sales by Manufacturer (2018-2019) (MT)
Table 56. Global Nifedipine Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Nifedipine Sales by Regions (2015-2020) (MT)
Table 58. Global Nifedipine Sales Market Share by Regions (2015-2020)
Table 59. Global Nifedipine Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Nifedipine Sales by Countries (2015-2020) (MT)
Table 61. North America Nifedipine Sales Market Share by Countries (2015-2020)
Table 62. North America Nifedipine Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Nifedipine Revenue Market Share by Countries (2015-2020)
Table 64. Europe Nifedipine Sales by Countries (2015-2020) (MT)
Table 65. Europe Nifedipine Sales Market Share by Countries (2015-2020)
Table 66. Europe Nifedipine Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Nifedipine Sales by Regions (2015-2020) (MT)
Table 68. Asia-Pacific Nifedipine Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Nifedipine Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Nifedipine Sales by Countries (2015-2020) (MT)
Table 71. South America Nifedipine Sales Market Share by Countries (2015-2020)
Table 72. South America Nifedipine Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Nifedipine Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Nifedipine Sales by Countries (2015-2020) (MT)
Table 75. Middle East & Africa Nifedipine Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Nifedipine Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Nifedipine Revenue Market Share by Countries (2015-2020)
Table 78. Global Nifedipine Sales by Type (2015-2020) (MT)
Table 79. Global Nifedipine Sales Share by Type (2015-2020)
Table 80. Global Nifedipine Revenue by Type (2015-2020) (USD Million)
Table 81. Global Nifedipine Revenue Share by Type (2015-2020)
Table 82. Global Nifedipine Sales by Application (2015-2020) (MT)
Table 83. Global Nifedipine Sales Share by Application (2015-2020)
Table 84. Global Nifedipine Sales Forecast by Regions (2021-2025) (MT)
Table 85. Global Nifedipine Market Share Forecast by Regions (2021-2025)
Table 86. Global Nifedipine Sales Forecast by Type (2021-2025) (MT)
Table 87. Global Nifedipine Market Share Forecast by Type (2021-2025)
Table 88. Global Nifedipine Sales Forecast by Application (2021-2025)
Table 89. Global Nifedipine Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nifedipine Picture
Figure 2. Global Sales Market Share of Nifedipine by Type in 2019
Figure 3. Nifedipine Controlled Release Tablets Picture
Figure 4. Nifedipine Extended Action Tablets Picture
Figure 5. Nifedipine Sales Market Share by Application in 2018
Figure 6. Primary Pulmonary Hypertension Picture
Figure 7. Heart Failure Picture
Figure 8. Others Picture
Figure 9. Global Nifedipine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Nifedipine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Nifedipine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Nifedipine Sales Market Share by Manufacturer in 2019
Figure 30. Global Nifedipine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Nifedipine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Nifedipine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 35. Global Nifedipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Nifedipine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Nifedipine Revenue Market Share by Regions in 2018
Figure 38. North America Nifedipine Sales and Growth Rate (2015-2020)
Figure 39. Europe Nifedipine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Nifedipine Sales and Growth Rate (2015-2020)
Figure 41. South America Nifedipine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Nifedipine Sales and Growth Rate (2015-2020)
Figure 43. North America Nifedipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Nifedipine Sales Market Share by Countries (2015-2020)
Figure 45. North America Nifedipine Sales Market Share by Countries in 2018
Figure 46. North America Nifedipine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Nifedipine Revenue Market Share by Countries in 2018
Figure 48. United States Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 49. Canada Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 50. Mexico Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 51. Europe Nifedipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Nifedipine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Nifedipine Revenue Market Share by Countries in 2019
Figure 54. Germany Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 55. UK Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 56. France Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 57. Russia Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 58. Italy Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 59. Asia-Pacific Nifedipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Nifedipine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Nifedipine Revenue Market Share by Regions 2019
Figure 62. China Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 63. Japan Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 64. Korea Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 65. India Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 66. Southeast Asia Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 67. South America Nifedipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Nifedipine Sales Market Share by Countries in 2019
Figure 69. South America Nifedipine Revenue Market Share by Countries in 2019
Figure 70. Brazil Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 71. Argentina Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 72. Middle East and Africa Nifedipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Nifedipine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Nifedipine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Nifedipine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 77. Egypt Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 78. Turkey Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 79. South Africa Nifedipine Sales and Growth Rate (2015-2020) (MT)
Figure 80. Global Nifedipine Sales and Growth Rate (2021-2025) (MT)
Figure 81. Global Nifedipine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Nifedipine Market Forecast (2021-2025) (MT)
Figure 83. Europe Sales Nifedipine Market Forecast (2021-2025) (MT)
Figure 84. Asia-Pacific Sales Nifedipine Market Forecast (2021-2025) (MT)
Figure 85. South America Sales Nifedipine Market Forecast (2021-2025) (MT)
Figure 86. Middle East & Africa Sales Nifedipine Market Forecast (2021-2025) (MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Bayer (Germany)
Yabao (China)
Pfizer (USA)
Actavis (USA)
Huanghai (China)
Teva (Israel)
Honglin (China)
Shyndec (China)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets